Skip navigation links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases


ICEID 2002

 Webcast

Sunday

Monday

Tuesday

   Wednesday
   Plenary Sessions
   Invited Panels
   Slide Sessions
   Meet the Experts and First Encounters
   A-Z Listing by Speakers
   A-Z Listing by Presentation Title
   A-Z Listing by Major Topic
   A-Z Listing by Agent or Disease
 Continuing Education Credits
 Program
 Organizing Committee
 Partners

ICEID 2000

International Conference on Emerging Infectious Diseases
ICEID Home Contact Us

ICEID 2002 Webcast
Presentations by Agents/Diseases

Note:
ICEID sessions that are not agent or disease-specific can be found on our other listings.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Presentations by Agents/Diseases
G-Q

Giardia duodenalis

A Molecular Approach to the Epidemiology of Giardia duodenalis in a Peruvian Shantytown
Paul Hoover, University of Arizona, Tucson, AZ
Gonorrhea
Multi-Drug Resistant Neisseria gonorrhoeae with Decreased Susceptibility to Cefixime, Hawaii, 2001
Susan Wang, CDC, Atlanta, GA
Group B Streptococcus

Antibiotic Susceptibility and the Mechanisms of Macrolide Resistance in Invasive Group B Streptococcus, Minnesota, 1998 and 2000
Joanne Bartkus, Minnesota Department of Health, Minneapolis, MN

Hantavirus Pulmonary Syndrome
Hantavirus Pulmonary Syndrome
Bruce Tempest, Gallup, NM

Hemolytic Uremic Syndrome

Postdiarrheal Hemolytic Uremic Syndrome in New York State
H.H. Chang, New York State Department of Health, Albany, NY
Hepatitis C Virus

Prevalence of Hepatitis C and other Chronic Liver Disease Etiologies in Primary Care Practices
Andre Sofair, Connecticut Emerging Infections Program, New Haven, CT

Hepatitis E Virus
Detection and Genetic Analysis of Swine Hepatitis E Virus in Farm Waste
Theresa Cromeans, CDC, Atlanta, GA
Histoplasmosis
Recurrent Histoplasmosis Outbreaks in Acapulco, Mexico
Yuri Roldán-Aragón, National Institute of Medical Science and Nutrition, Mexico City, Mexico
HIV/AIDS

Global Drug Resistance: The Case of Streptococcus pneumoniae
Keith Klugman, School of Public Health, Emory University, Atlanta, GA

Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic Model for Addressing Priority Infectious Diseases)
Bill Steiger, U.S. Department of Health and Human Services, Washington DC

HIV in the Older Patient
Bradley Bender, University of Florida, Gainesville, FL

Sex Workers as Targets of and Agents for HIV/STI Prevention
Rafael Mazin, Pan American Health Organization HCA/HCP, Washington, DC

Use of Antiretroviral Agents in Developing Countries
Peter Mugyenyi, Joint Clinical Research Center, Kampala, Uganda

Influenza

Acute Respiratory Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June 2001
Diaa Salman, U.S. Naval Medical Research Unit No 3., Cairo, Egypt

Analysis of a Health Indicator Surveillance System: Its Ability to Detect Annual Influenza Activity for the 1999-2000 and 2000-2001 Seasons Compared to Traditional Surveillance Systems
Ji-Eun Lee, Department of Defense Global Emerging Infections System, Silver Spring, MD

A DoD Global Influenza Surveillance Program
Linda Canas, Brooks Air Force Base, San Antonio, TX

Geographical Coherence of Influenza Epidemics in the U.S., France, and Australia: 1978-1998
Cecile Viboud, INSERM U444, Paris cedex 12, France

Improving Influenza and Pneumococcal Vaccination Rates for People 65+ in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health, Providence, RI

Influenza Surveillance in New York State, 1998-2001
Marilyn Kacica, New York State Department of Health, Albany, NY

PER.C6: A Human Designer Cell Line Providing a Pandemic-Proof Platform for the Manufacturing of Safe Influenza Vaccines
Fons UytdeHaag, Crucell Holland BV, Leiden, The Netherlands

Shared Animal and Human Influenza Viruses: A Role in the Next Pandemic?
Kennedy Shortridge, University of Hong Kong, Queen Mary Hospital, Hong Kong

Using CUSUM Techniques to Identify Influenza Outbreaks
Michael Stoto, The Rand Corporation, Arlington, VA

Virology of 1918 Flu Pandemic
Ann Reid, Armed Forces Institute of Pathology, Washington, DC

La Crosse Virus

Detection of La Crosse Virus in Cerebrospinal Fluid and Tissues by Reverse Transcription-Polymerase Chain Reaction
Brett Slater, New York State Department of Health, Slingerlands, NY

Leishmaniasis

Emergence of Canine Visceral Leishmaniasis in Dogs in North America
Zandra Duprey,
CDC, Atlanta, GA
Lyme Disease

Clinical Management and Outcomes of Lyme Disease in Wisconsin
Daniel O'Leary, CDC, Fort Collins, CO

Lyme Disease Incidence in Wisconsin: A Comparison of State Reported Rates with Rates from a Population-Based Cohort
Allison Naleway, Marshfield Medical Research Foundation, Marshfield, WI

Risk Factors for Lyme Borreliosis: A German Case-Control Study
Andrea Ammon, Robert Koch Institute, Berlin, Germany

Lymphatic Filariasis
Eradication of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center, Rollins School of Public Health, Emory University, Atlanta, GA
Malaria

Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic Model for Addressing Priority Infectious Diseases)
Bill Steiger, U.S. Department of Health and Human Services, Washington DC

Increasing Detection of Malaria in U.S. Hospitals Using the OptiMAL Rapid Diagnostic Test
Carol Palmer, University of Florida, Gainesville, FL

In vivo Sensitivity of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine During an Outbreak of Malaria in Burundi, 2001
François Dantoine, Epicentre, Paris, France

New Strategies on the Old Ideas: Malaria Control Without Insecticides and Community Participation in Aedes aegypti Control, Mexico's Experiences
Jorge F. Méndez-Galván, Ministry of Health, Mexico City, Mexico

Meningococcal Disease

The Emergence of Serogroup Y Disease and the Epidemiology of Invasive Meningococcal Disease in Colorado, 1997-2001
Lucinda Hammond, Colorado Department of Public Health and Environment, Denver, CO

Group B Meningococcal Vaccines
Gustavo Sierra, Finlay Institute, Havana, Cuba

Metapneumovirus

First Isolation of Human Metapneumovirus in Australia
Theo Sloots, Royal Children's Hospital and Royal Brisbane Hospital, Brisbane, Australia

The New Human Metapneumovirus
Albert Osterhaus, University of Rotterdam, Rotterdam, The Netherlands

Norwalk-Like Virus

see Calicivirus

Pneumonia

Failure to Detect C. pneumoniae in Atherosclerotic Specimens
Silvio Pitlik, Rabin Medical Center, Petah Tikvah, Israel

Global Drug Resistance: The Case of Streptococcus pneumoniae
Keith Klugman, School of Public Health, Emory University, Atlanta, GA

Improving Influenza and Pneumococcal Vaccination Rates for People 65+ in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health, Providence, RI

Onchocerciasis
Eradication of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center, Rollins School of Public Health, Emory University, Atlanta, GA
Q Fever

Investigation of Q Fever in Bosnia-Herzegovina, 2000: An Example of International Cooperation
Jennifer McQuiston, CDC, Atlanta, GA

A Neighborhood Outbreak of Q Fever Linked to a Goat Ranch in California
Michele Jay, California Department of Health Services, Sacramento, CA

Q Fever in the United States: Experience of Infectious Disease Consultants and Comparison to National Reporting During 2000
Jennifer McQuiston, CDC, Atlanta, GA

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Top of Page

  Top of Page

 

ICEID Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed May 3, 2002

International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Privacy Policy | Accessibility
 

 U.S. Department of Health and Human Services (HHS)